Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIPSS: Hydrocortisone in Pediatric Septic Shock
NCT03401398Phase 3Recruiting
- Start
- Mar 2019
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 10
01
Overview
A Phase 3 trial of hydrocortisone sodium succinate in septic shock. Started Mar 2019; status: recruiting.
02
Drugs
hydrocortisone sodium succinate
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03401398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03401398.